- I
-
Ibanez Lopez, Antonio Santiago
Massachusetts Institute of Technology
-
Antonio Santiago Ibanez Lopez
-
Ibraheem, Olawunmi
University of Maryland School of Medicine
-
Olawunmi Ibraheem
-
Ida, Fidelia
MCPHS University
-
Fidelia Ida
-
Fidelia Ida
-
Fidelia Ida
-
Idigo, Adeniyi
University of Alabama Birmingham
-
Adeniyi Idigo
-
Ientile, Valentina
University of Messina, Italy
-
Valentina Ientile
-
Valentina Ientile
-
Valentina Ientile
-
Valentina Ientile
-
Ihekweazu, Chikwe
Nigeria CDC
-
Chikwe Ihekweazu
-
Ikram, M.Kamran
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
-
M.Kamran Ikram
-
Illoh, Onyekachukwu
-
Onyekachukwu Illoh
-
Ilomaki, Jenni
Monash University
-
Jenni Ilomaki
-
Jenni Ilomaki
-
Imai, Shinobu
-
Shinobu Imai
-
Imthurn, Bruno
University of Zurich
-
Bruno Imthurn
-
Inada, Isa
Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University
-
Isa Inada
-
Indrajaya, Sudi
Departement of Pharmacology & Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada
-
Sudi Indrajaya
-
Inglis, Tiffany
Anthem
-
Tiffany Inglis
-
Ingrasciotta, Ylenia
-
Ylenia Ingrasciotta
-
Ylenia Ingrasciotta
-
Inouye, SHARON
Harvard Medical School, Boston, MA
-
SHARON Inouye
-
Insani, Widya Norma
Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.
-
Widya Norma Insani
-
Widya Norma Insani
-
Inweregbu, Stella
Nigeria CDC
-
Stella Inweregbu
-
Ip, Patrick
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
-
Patrick Ip
-
Irving, Stuart
University of East Anglia
-
Stuart Irving
-
Irwin, Debra
Aetion, Inc
-
Debra Irwin
-
Debra Irwin
-
Debra Irwin
-
Isgrò, Valentina
Department of Diagnostics and Public Health, University of Verona, Verona, Italy
-
Valentina Isgrò
-
Isherwood, Tara
Syneos Health
-
Tara Isherwood
-
Ismail Atta, Sherin
UNC Gillings School of Global Public Health
-
Sherin Ismail Atta
-
Ismaila, Afisi
Value Evidence and Outcomes, GSK, Collegeville, PA, USA
-
Afisi Ismaila
-
Issac, Aleena
Mary Queen's Mission Hospital, Kanjirapally
-
Aleena Issac
-
Aleena Issac
-
Aleena Issac
-
Aleena Issac
-
Aleena Issac
-
Itaya, Takahiro
University College London
-
Takahiro Itaya
-
Ittermann, Till
Institute for Community Medicine, University Medicine Greifswald
-
Till Ittermann
-
Ives, Timothy
Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
-
Timothy Ives
-
Iyer, Ravi
Teva Pharmaceutical Industries
-
Ravi Iyer
-
Izquierdo, Miguel
Clinical Development Oncology, Novartis, Basel, Switzerland
-
Miguel Izquierdo
-
Miguel Izquierdo
-
Izurieta, Hector
US Food and Drug Administration
-
Hector Izurieta
-
Hector Izurieta
-
Hector Izurieta
-
Hector Izurieta